Skip to main content
Verified by IngredientMD/Ritual/Essential for Women 50+
VERIFIED BYingredientMD

Essential for Women 50+.

Strong evidence, strong doseRitual, verified Oct 2026Formula verified. Independently reviewed.Independent review. Not commissioned by Ritual.

DHA (Docosahexaenoic Acid) is the lead active here, studied most for omega 3 index. Magnesium is the most studied active here, with 21 human studies behind it, each one cited. Each serving carries 330 mg of DHA (Docosahexaenoic Acid), inside the range the published research used. Who it fits: made for women, adults.

Clinically dosedFull label disclosure
8Active ingredientsWell studiedResearch base107Human studies
Essential for Women 50+Verified by IngredientMD
RitualIngredientMD
The verdict
Strong evidence, strong dose
For Made for women, adults.
How we verify

The brand submits the formula. We read the supplement facts panel and weigh dose, form and synergy against the clinical evidence. Labs test. IngredientMD verifies. The fee pays for review time, never for the outcome.

The formula
Vitamin D3: Filling everyday nutrient gapsExtensively studied
Vitamin E: Filling everyday nutrient gapsWell studied
Folate: MethylationExtensively studied
Vitamin B12: Vitamin B12 statusExtensively studied
Magnesium: Magnesium statusExtensively studied
DHA (Docosahexaenoic Acid): Omega 3 indexKey driver
Boron: Magnesium statusWell studied
Vitamin K2: Filling everyday nutrient gapsExtensively studied

How we read this product

Source: Supplement facts
Supplement Facts panel for Essential for Women 50+
  1. 01
    We read the label.

    The panel on the left is the one we evaluated, line by line.

  2. 02
    Every active, separately.

    All 8 actives checked against the clinical evidence: dose, form, and what the research actually shows.

  3. 03
    Then the formula as a whole.

    Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Strong evidence, strong dose".

  4. 04
    Earned, not bought.

    The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.

Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.

The receipts

Well studied
Research base
107
Human studies
330 mg
DHA (Docosahexaenoic Acid)
50 mcg
Vitamin D3
330 mg per serving sits inside the studied 200 mg-500 mg range
DHA (Docosahexaenoic Acid), Mozaffarian & Rimm 2006 JAMA systematic review; ISSFAL 2004 recommendations
100 mcg per serving sits inside the studied 45 mcg-100 mcg range
Vitamin K2, Knapen 2013 + Geleijnse 2004 Rotterdam study

Cross-checked against 1,463 documented interactions for these actives.

Read the evidenceVitamin D3, the evidence →Vitamin E, the evidence →Folate, the evidence →Vitamin B12, the evidence →Magnesium, the evidence →DHA (Docosahexaenoic Acid), the evidence →

Inside the formula

Vitamin D3
20 studies
Filling everyday nutrient gaps
Extensively studied
Vitamin E
15 studies
Filling everyday nutrient gaps
Well studied
Folate
12 studies
Methylation
Extensively studied
Vitamin B12
17 studies
Vitamin B12 status
Extensively studied
Magnesium
21 studies
Magnesium status
Extensively studied
DHA (Docosahexaenoic Acid)
Omega 3 index
Studied 200 mg to 1.5 g a day
Key driver
Boron
Magnesium status
Well studied
Vitamin K2
13 studies
Filling everyday nutrient gaps
Studied 45 mcg to 500 mcg a day
Extensively studied
In context

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

39 more
The people it speaks to

60.2% of US adults aged 20 and over

took a dietary supplement in the past 30 days, and 38.7% took two or more, in the 2021 to 2023 National Health and Nutrition Examination Survey.

CDC National Center for Health Statistics, 2026
Daily use

59 to 66 days

was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.

Systematic review and meta-analysis, 2024
Vitamin K2

Meta-analysis, 2022

Across nine trials in postmenopausal women, vitamin K2 raised lumbar spine bone density by about 2.2 percent and forearm bone density by about 1.6 percent compared with control.

Journal of Bone and Mineral Metabolism
Vitamin K2

Randomised trial, 2013

In healthy postmenopausal women, three years of 180 micrograms a day of MK-7 slowed bone density loss at the spine and hip, and improved bone strength.

The paper
Knapen et al., 2013PMID 23525894
Vitamin E

Meta-analysis, 2022

Across 8 trials in 1,002 women, vitamin E taken by mouth reduced reported menstrual cramp pain compared with placebo, with the clearest effect in the first month.

Clinical Nutrition ESPEN
Vitamin K2

Meta-analysis, 2025

In nine trials of 2,570 older women with low bone mass, vitamin K2 changed blood signals tied to bone turnover, not actual bone strength.

Front Endocrinol
DHA (Docosahexaenoic Acid)

Meta-analysis, 2011

In trials giving DHA by itself, DHA lowered triglycerides and raised HDL cholesterol by about 4.5 mg/dL compared with placebo.

The paper
Vitamin K2

Meta-analysis, 2025

Across six mostly observational studies in 2,327 Japanese adults, habitual natto intake linked to much higher blood MK-7 and modestly greater bone density, a food-intake association, not a measured effect.

Front Nutr
Vitamin K2

Randomised trial, 2020

In this trial of a low daily MK-7 amount, bone mineral density changed over the study period in the group given it, an imaging measurement, not a clinical event.

Calcified Tissue International
Vitamin E

Randomised trial, 2023

In 160 postmenopausal women with long-standing sleep difficulty, one month of vitamin E brought the median sleep questionnaire score to 6, versus 9 on placebo, where lower means better sleep.

Nutrients
Vitamin D3

Meta-analysis, 2024

Across 10 trials in 318 athletes, vitamin D3 raised blood vitamin D by about 14.8 nmol/L and hinted at better muscle strength, though few trials leave that uncertain.

Frontiers in Nutrition
Vitamin D3

Randomised trial, 2025

Vitamin D3 supplementation changed the inflammatory protein CHI3L1 and oxidative stress markers in adults with a chronic demyelinating condition. These are markers, not clinical outcomes.

Neuropsychopharmacology Reports
Vitamin E

Meta-analysis, 2025

Across 21 trials, vitamin E lowered oxidized LDL and lengthened the time before LDL starts to oxidize, by about 20.45 units, both lab markers of oxidation.

European Journal of Pharmacology
DHA (Docosahexaenoic Acid)

Meta-analysis, 2026

Across 9 placebo-controlled eccentric exercise trials in healthy adults, supplements combining DHA with EPA reduced delayed onset muscle soreness (Hedges g -0.75, 95% CI -1.14 to -0.36). The wider body of 43 studies was mixed, and the trials tested the two fats together rather than DHA alone.

Nutrients
Vitamin D3

Meta-analysis, 2024

Across 20 studies, daily vitamin D3 raised blood vitamin D levels by about 10.4 nmol/L more than the same dose of vitamin D2, roughly 40 percent more.

Advances in Nutrition
Vitamin E

Meta-analysis, 2023

Across 12 trials in 794 adults with high liver fat, at least 400 IU of vitamin E daily lowered two liver enzyme markers by 7 to 10 and 5 units.

Nutrients
Vitamin D3

Meta-analysis, 2014

Across 23 trials of 4,082 adults, vitamin D raised bone mineral density at the femoral neck by about 0.8%, with no measurable change at the spine, hip, or other sites.

Lancet
Vitamin K2

Systematic review, 2026

The authors report that effects on glycaemic measures differ across groups with differing baseline blood sugar status, so results are not uniform across populations. The outcomes assessed are blood markers.

Nutrients
DHA (Docosahexaenoic Acid)

Randomised trial, 2010

Formula-fed infants given DHA-enriched formula from 0.32% of fatty acids developed better visual acuity by 12 months than infants on DHA-free formula.

American Journal of Clinical Nutrition
DHA (Docosahexaenoic Acid)

Meta-analysis, 2024

Pooling 9 randomised trials of DHA given before or after birth, infants in the DHA groups scored 1.47 points higher on the Psychomotor Development Index (95% CI 0.23 to 2.72), with no difference detected on the Mental Development Index.

Frontiers in Neurology
Vitamin E

Meta-analysis, 2026

Pooling the available trials, adjuvant vitamin E alongside varicocele surgery was associated with better post-operative semen parameters, which are laboratory markers of sperm quality and not fertility outcomes.

Archivio Italiano di Urologia e Andrologia

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

What this formula earned

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

  • Studied in people21 human studies on Magnesium back this formula, each one cited.
  • A mechanism that is settledHow Vitamin D3 and Vitamin E work is settled pharmacology.
  • Studied together, not just separatelyVitamin D3 and Vitamin E have been studied together, not only separately.
  • Recent work on the recordThe most recent study on this record was published in 2026.
  • Serving amount inside the studied rangeEach serving carries 330 mg of DHA (Docosahexaenoic Acid), inside the range the published research used.
  • A stated daily maintenance amountDHA (Docosahexaenoic Acid) is here at a daily maintenance amount, which is what a daily supplement is for.
  • Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
  • The exact form, describedThe label names its forms exactly: Vitamin D3 in a carrier oil, lanolin-derived, d-alpha-tocopherol (natural), Folinic acid. The record says what each one is and what it suits.
  • Full label disclosureEvery ingredient on this label carries its own declared amount.
  • Where it comes from and how it is madeVitamin D3 is made by more than one route.
  • Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
  • A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.
Studied together

The combinations the trials actually measured.

One pairing in this formula has been studied as a combination in human trials. Each finding below is what a named study measured, cited and dated, never written by the brand.

  • Vitamin D3 + Vitamin K2Bone

    In a meta-analysis of eight randomized trials, vitamin K2 taken together with vitamin D raised total bone mineral density and lowered undercarboxylated osteocalcin, a marker of vitamin K status.

    Promising

Research strength. Research strength says how much work stands behind the combination. It is never a product score.

Fail closed. Where actives were studied on their own rather than together, each shows on its own evidence, never a combined effect no trial measured.

Independent record. Every finding is cited to a named trial, dated, and never written by the brand.

Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.

What the trials show

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

  • Vitamin D3about 3 months of daily useBuilds with daily use

    In the trial record, blood vitamin D rises for about 3 months of daily vitamin D3 and then holds at a plateau, near 69 nmol/L at 1,000 IU a day, from a starting level near 41 nmol/L.

    Early
  • Vitamin Eabsorbed slowly, tracked over 72 hoursMeasured within a day

    In a 3-phase crossover using two deuterium-labelled forms of alpha-tocopherol, healthy women absorbed about 55 percent of an oral dose taken with a 40 percent fat meal and about 64 percent with a fat-free meal, with samples tracked over 72 hours. The authors conclude absorption is not limited by absent fat or fasting, and that vitamin E leaves the intestine by a prolonged process.

    Promising
  • Folatea median of about 36 weeks of daily intakeBuilds with daily use

    A systematic review and Bayesian meta-analysis drew on 108 articles from 14,002 screened records and modelled blood folate against folic acid intake using one-compartment pharmacokinetic models. Red blood cell folate rose 1.78 fold from baseline to steady state at 375 to 570 ug folic acid per day, and reaching that steady state took a median of 36 weeks, 95% credible interval 27 to 52 weeks. Serum or plasma folate rose 11.6% for every 100 ug per day of folic acid intake, 95% credible interval 8.4 to 14.9.

    Strong
  • Folateabout 18 days for serum folate to reach its maximumBuilds with daily use

    A kinetic study in six healthy men aged 22 to 31 gave 3.6 umol per day, 1.6 mg, of deuterium-labelled folic acid for four weeks, with folate tracked in serum, erythrocytes and urine by microbiological assay and gas chromatography mass spectrometry. Serum folate reached its maximum concentration in about 18 days, while isotopic labelling of erythrocyte folate kept rising across the whole four weeks. After supplementation stopped, red blood cell folate and urinary folate excretion declined linearly, and serum folate fell with a slow-phase half-life of 18.7 days. One study, six men, no control group.

    Early
  • Vitamin B12about 16 weeks of daily oral useBuilds with daily use

    A randomised, double-blind, parallel-group dose-finding trial in 120 older people with mild vitamin B12 deficiency, defined as serum B12 of 100 to 300 pmol/L with methylmalonic acid at or above 0.26 umol/L, gave daily oral cyanocobalamin at 2.5, 100, 250, 500 or 1000 ug for 16 weeks. Mean plasma methylmalonic acid fell 16%, 16%, 23%, 33% and 33% across those doses. Daily doses of 647 to 1032 ug accounted for 80% to 90% of the estimated maximum reduction. The window was measured on a blood marker of B12 status, not on a symptom.

    Promising
  • Vitamin B12serum levels peak about seven hours after a single tabletMeasured within a day

    An open-label randomised single-dose pharmacokinetic study in 20 healthy men aged 20 to 45, conducted and authored by staff of Emisphere Technologies, the developer of the SNAC carrier under test, measured serum vitamin B12 after one 5 mg cyanocobalamin tablet, with six men on the marketed tablet. Time to peak serum B12 was 6.83 hours for the marketed tablet and 0.5 hours for the carrier coformulation. Absolute bioavailability was 2.16% and 5.09% respectively. One trial, six men per arm. Serum concentration was measured, not any symptom.

    Early
5 more
  • DHA (Docosahexaenoic Acid)about eight weeks of daily useBuilds with daily use

    In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.

    Cao et al., 2006PMID 17053155
    Promising
  • DHA (Docosahexaenoic Acid)about five to seven days of daily useBuilds with daily use

    In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.

    Gabbs et al., 2021PMID 33097936
    Promising
  • Boronabout one week of daily useBuilds with daily use

    The same eight healthy men then took 10 mg of boron daily with breakfast for seven days, with an 8 a.m. blood draw on day seven. Mean plasma free testosterone increased and mean plasma estradiol decreased significantly, while dihydrotestosterone, cortisol and vitamin D were elevated and all three inflammatory markers fell. The authors describe this as the first human report of a rise in free testosterone after boron intake. There is no placebo arm across the seven days and the sample is eight men, so the one-week figure rests on a single small study.

    Early
  • Vitamin K2about four weeks of daily useBuilds with daily use

    A double-blind randomised dose-finding trial gave 60 postmenopausal women aged 50 to 69 either 0, 50, 100 or 200 micrograms of menaquinone-7 daily for four weeks on a controlled diet. The ratio of carboxylated to undercarboxylated osteocalcin rose dose dependently, with significant differences from the 0 microgram group at 100 and 200 micrograms. A companion 12-week trial in 120 people aged 20 to 69 confirmed the change at 100 micrograms daily. Both studies were run by authors affiliated with the R and D division of J-Oil Mills. An independent 8-week double-blind trial in 55 healthy prepubertal children found the same direction at 45 micrograms daily. What was measured is a blood marker of vitamin K status, not bone density and not a sensation.

    Promising
  • Vitamin K2three years of daily use, with measurements at one, two and three yearsBuilds with daily use

    A double-blind randomised trial gave 244 healthy postmenopausal women either placebo or 180 micrograms of menaquinone-7 daily for three years, with bone mineral density measured by DXA at baseline and after each year. Menaquinone-7 decreased the age-related decline in bone mineral content and bone mineral density at the lumbar spine and femoral neck, but not at the total hip. The effect is a slowed decline rather than a gain, and the trial ran three years rather than weeks.

    Promising

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

General timing

How each ingredient usually behaves over time.

8 ingredients, from each one's own page.

2 more
  • Boron

    Plasma boron tracks intake within a day or two because it isn't stored. The change shows up in mineral balance and hormone measures over a week or two.

    Its own page, the plain answer on timing

  • Vitamin K2Days, not hours

    Days for absorption, weeks for the marker. Undercarboxylated osteocalcin falls across roughly four to twelve weeks of daily intake, and that is a status marker rather than an outcome.

    Its own page, the plain answer on timing

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

Chemical form

The same ingredient, carried differently.

What each form is, and where it fits in a formula. Measured findings carry the study that reported them.

  • Cholecalciferol (vitamin D3)

    The animal-sourced form of vitamin D, made in skin under UVB light and produced commercially from lanolin. Fat-soluble, so it travels with dietary fat and is stored in body fat.

    Fits
    Raising and holding vitamin D status, and the form most supplement trials use.
    Trade-off
    Being fat-soluble it accumulates with sustained high dosing, so intakes are set against the tolerable upper level rather than topped up freely.

    In a 12-week double-blind randomised controlled trial in 108 young women in urban Bangalore, most of whom began vitamin D-deficient, daily vitamin D3 at 400, 600 or 800 IU in a fortified wafer raised serum 25-hydroxyvitamin D, parathyroid hormone fell over time, and effects on bone-turnover markers were modest and not dose specific. The 800 IU dose brought 65 percent of participants to sufficiency.

  • Glucosamine salt of 5-MTHF (Quatrefolic)

    The same (6S)-5-methyltetrahydrofolate molecule paired with glucosamine rather than calcium. Changing the counter-ion changes how the powder behaves, not what the folate is: the glucosamine salt dissolves readily in water, where a calcium salt tends to sit as a suspension, and it comes standardised on a carrier at a declared folate percentage.

    Fits
    Fits liquid and dissolving formats: drops, syrups, effervescent tablets, sachets stirred into water, and clear beverages where undissolved particles would be visible. Also used where a formulator wants a methylfolate without adding to the calcium declared in the mineral row. The glucosamine in the commercial material is manufactured rather than shellfish derived, though the supplier specification is what an allergen statement has to rest on.
    Trade-off
    Published human work naming this specific salt is limited, and most of what is documented about methylfolate was done on the calcium salt, so the two are not interchangeable in a dossier. It carries the same light, oxygen and moisture sensitivity as any reduced folate, needs the same dietary folate equivalent conversion on the panel, and the glucosamine portion is inert weight that the microgram maths has to account for.
  • Calcium fructoborate

    A calcium salt of a boron-carbohydrate ester in which boron is diesterified with fructose, matching the sugar-borate complexes boron naturally forms in edible plants.

    Fits
    Reproduces the plant form of dietary boron and ships as a branded, structurally characterised ingredient (FruiteX-B), which suits formulas that want a boron source with a documented, defined structure.
    Trade-off

    In a double-blind, placebo-controlled randomised trial of 60 adults with self-reported knee discomfort, 110 mg of calcium fructoborate taken twice daily produced larger within-subject reductions in WOMAC and McGill Pain Questionnaire scores than placebo at both day 7 and day 14.

Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.

Format

Capsule

It is a capsule, so the amount per serving is fixed and travels without measuring.

Best forMost standard doses, and anywhere a short, clean label is the point.
From the same shelf

Studied alongside this brand's other formulas

Where two of this brand's products carry actives the literature has read together, the pairing and its basis are below. The evidence word is the corpus row's own confidence, never a score.

Recurring supply suggested

Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.

Questions shoppers ask

Is Essential for Women 50+ independently verified?
Yes. IngredientMD reviewed this formula independently and verified it in Oct 2026. The verdict is earned, not bought: brands can't edit or purchase it.
What's in Essential for Women 50+?
Essential for Women 50+ is built on Vitamin D3, Vitamin E, Folate, Vitamin B12, Magnesium, DHA (Docosahexaenoic Acid), and more. Each ingredient links to its own evidence page on IngredientMD.
Were ingredient interactions checked?
Yes. The combination was screened against 1,463 documented interactions for these actives in IngredientMD's interaction database.
Who is IngredientMD?
IngredientMD is an independent supplement-science platform. We analyze ingredients and formulas against clinical research, and we verify products only when they clear our bar. Labs run the tests. We review the results.
Sell a formula this good?

Put an earned verification on your own product page.

Get verified

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.

Independent review by IngredientMD, not commissioned by RitualWork at Ritual? This verification is yours to claim →